Drugs / NeuMed
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07198659 | Jul 2025 → Jul 2027 expected | pancreas disorder | The First Affiliated Hospital of Air Force Medicial University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NeuMed | “The goal of this clinical trial is to learn if Autologous Drug-Loaded Neutrophils (NeuMed) can treat patients with Unresectable Pancreatic Cancer.” NCT07198659 ↗ |
| Known as | Autologous Drug-Loaded Neutrophils (NeuMed) | “The goal of this clinical trial is to learn if Autologous Drug-Loaded Neutrophils (NeuMed) can treat patients with Unresectable Pancreatic Cancer.” NCT07198659 ↗ |
| Modality | Cell therapy | “Autologous Drug-Loaded Neutrophils (NeuMed)” NCT07198659 ↗ |